Dutasteride

Therapeutic delivery · 2025

Researchers found that androgenic alopecia, affecting many men and women, can significantly impact mental health. They observed that dutasteride, a medication typically used for prostate issues, shows promise as a treatment for hair loss but faces challenges in creating a safe topical version. The study aims to find a way to deliver dutasteride directly to hair follicles while minimizing its absorption into the bloodstream.

• Androgenic alopecia affects 80% of men and 50% of women in their lifetimes.
• Dutasteride is gaining popularity as a treatment for hair loss.
• Developing a safe topical product for dutasteride is challenging.

Dermatology (Basel, Switzerland) · 2024

Researchers observed that dutasteride may be more effective than finasteride for treating androgenetic alopecia, a common cause of hair thinning. They noted that while dutasteride has mild side effects, there are concerns about sexual and psychiatric risks. Additionally, new methods like microneedling and topical formulations are being explored to improve treatment outcomes.

• Dutasteride shows better efficacy than finasteride for hair loss.
• Most side effects of dutasteride are mild and reversible.
• New treatment methods, including topical formulations, are under development.

The Journal of dermatological treatment · 2022

Researchers observed that dutasteride is likely the most effective oral treatment for male hair loss, followed by finasteride and minoxidil. While finasteride is FDA-approved, minoxidil and dutasteride are used off-label, with some countries recently approving dutasteride. Each medication has different side effects, with minoxidil primarily causing excessive hair growth and cardiovascular symptoms, while finasteride and dutasteride may lead to sexual dysfunction.

• Dutasteride is probably the most effective treatment for androgenetic alopecia.
• Finasteride is FDA-approved, while minoxidil and dutasteride are used off-label.
• Minoxidil can cause excessive hair growth and cardiovascular issues, while finasteride and dutasteride may lead to sexual side effects.

The world journal of men's health · 2020

Researchers observed that long-term use of finasteride and dutasteride, medications commonly prescribed for prostate issues and hair loss, may lead to serious health risks. These include non-alcoholic fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease, and potential kidney dysfunction.

• Long-term use of finasteride and dutasteride may cause non-alcoholic fatty liver disease (NAFLD).
• These medications could contribute to insulin resistance and type 2 diabetes.
• Users may experience dry eye disease and potential kidney dysfunction.

Acta dermato-venereologica · 2019

Researchers found that treatment for male pattern baldness with finasteride or dutasteride may increase the risk of sexual dysfunction. Specifically, finasteride was linked to a higher risk compared to dutasteride, although the evidence for dutasteride was less conclusive. More studies are needed to better understand the effects of dutasteride.

• Finasteride increases the risk of sexual dysfunction by 66%.
• Dutasteride also carries a risk, but the evidence is less certain.
• Further research is needed to clarify the effects of dutasteride.

Dermatology online journal · 2017

Researchers observed that the medications finasteride and dutasteride, often used for hair loss and prostate issues, can lead to sexual side effects such as impotence, reduced sexual desire, and problems with ejaculation. The review compares these effects between the two drugs and different dosages.

• Both finasteride and dutasteride can cause sexual dysfunction.
• Impotence, decreased libido, and ejaculation disorders are common side effects.
• The review compares the sexual side effects of different dosages and between the two medications.

Current clinical pharmacology · 2017

Researchers found that dutasteride, a medication that inhibits an enzyme linked to hair loss, shows promise as a treatment for androgenetic alopecia, a common form of hair thinning. They observed that dutasteride may be more effective than the currently approved drug finasteride, with similar side effects, suggesting it could become a preferred option for managing this condition in the future.

• Dutasteride effectively inhibits the enzyme responsible for hair loss.
• It has shown better results than finasteride in clinical trials.
• Dutasteride has comparable side effects to finasteride.

Journal of the American Academy of Dermatology · 2014

Researchers found that dutasteride, a medication for hair loss, significantly increased hair count and width in men with androgenetic alopecia compared to finasteride and a placebo. The study showed that dutasteride was generally well tolerated, with similar side effects across all treatment groups.

• Dutasteride at 0.5 mg/d led to greater hair growth than both finasteride and placebo.
• Hair count and width increased with higher doses of dutasteride.
• The treatment was well tolerated with similar adverse events across all groups.